Center Book Partners LP Bio N Tech Se Transaction History
Center Book Partners LP
- $1.54 Billion
- Q4 2024
A detailed history of Center Book Partners LP transactions in Bio N Tech Se stock. As of the latest transaction made, Center Book Partners LP holds 194,118 shares of BNTX stock, worth $18.7 Million. This represents 1.43% of its overall portfolio holdings.
Number of Shares
194,118
Previous 119,462
62.49%
Holding current value
$18.7 Million
Previous $14.2 Million
55.9%
% of portfolio
1.43%
Previous 0.92%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
364Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$791 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$424 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$413 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$182 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$174 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...